What is Strata Critical Medical, Inc.'s market cap?

Strata Critical Medical, Inc. (SRTA) has a market capitalization of $444.7M and trades on NASDAQ.

What is Strata Critical Medical, Inc.'s revenue and profitability?

Strata Critical Medical, Inc. generated $254.3M in trailing twelve-month revenue with net income of $52.3M, representing a net margin of 21.0%. Gross margin stands at 21.7%, with free cash flow of -$56.9M. These figures are based on the Q1 2026 filing.

Who are Strata Critical Medical, Inc.'s competitors?

Strata Critical Medical, Inc.'s key competitors include TransMedics Group, Inc. Common Stock, Universal Logistics Holdings, Inc. Common Stock, Landstar System Inc, and others. These companies compete in similar markets and product categories.

What subsidiaries does Strata Critical Medical, Inc. have?

Strata Critical Medical, Inc.'s subsidiaries include Trinity Medical Solutions, Keystone Perfusion Services LLC.

Where is Strata Critical Medical, Inc. headquartered?

Strata Critical Medical, Inc. is headquartered in United States of America. It has been publicly traded since 2021.

SRT

Strata Critical Medical, Inc.

SRTA

Strata Critical Medical is a specialized provider of time-critical logistics and clinical services for the United States healthcare industry, primarily focusing on the transplant ecosystem.

Market cap

$444.75M+36.1%

Revenue$254.3M+44.2%

Net income$52.3M+292%

Free cash flow-$56.9M-187%

EPS (diluted)$0.64+278%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$67.4MBeat by $3.7M EPS$0.03Beat by $0.07

Read the full report

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$67.2M

EPS estimate-$0.04

Financials

Q1 2026

Income statement

See full

Revenue$67.4M+87.4%

Gross profit$14.1M+100%

Operating income-$3.0M+47.7%

Net income$2.2M+162%

EPS (diluted)$0.03+175%

Balance sheet

See full

Cash & equivalents$59.0M+65.3%

Total debt$4.5M-50.7%

Total equity$285.7M+30.0%

Total assets$327.6M+30.8%

Cash flow

See full

Operating cash flow$3.9M+1,679%

CapEx$5.2M+98.1%

Free cash flow-$1.3M+54.8%

Valuation & ratios

Valuation

See full

Market cap$444.75M+36.1%

Enterprise value$390.23M—

P/E8.5×—

P/S1.8×—

Profitability

See full

Gross margin21.7%+1.3pp

Operating margin-7.8%-2.8pp

FCF margin-22.4%+1,712pp

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio5.9×-1.0×

Segments

By segment

See full

Logistics$47.6M—

Clinical$19.8M—

By product

See full

Other Clinical$9.9M—

Transplant Clinical$9.8M—

Competitors

By market cap

Landstar System$6.5B+31.8%

Schneider National$6.4B+42.8%

Matsons$6.2B+76.5%

HUB Group$2.9B+34.2%

TransMedics Group, Inc.$2.6B-27.9%

Forward Air$465.5M-52.6%

SRT

Strata Critical Medical, Inc.$444.7M—

Universal Logistics Holdings, Inc.$375.5M-47.1%

By revenue growth

SRT

Strata Critical Medical, Inc.+44.2%

TransMedics Group, Inc.+30.2%

Schneider National+5.5%

Landstar System+4.1%

Forward Air-3.2%

Matsons-4.6%

Universal Logistics Holdings, Inc.-11.1%

By net margin

TransMedics Group, Inc.27.04%+17.0pp

SRT

Strata Critical Medical, Inc.20.99%+36.1pp

Matsons12.92%-1.8pp

Landstar System2.64%-0.9pp

Schneider National1.73%-0.6pp

Forward Air-3.71%+27.9pp

Universal Logistics Holdings, Inc.-7.09%-11.9pp

Profile

Strata Critical Medical is a specialized provider of time-critical logistics and clinical services for the United States healthcare industry, primarily focusing on the transplant ecosystem. The company offers an integrated 'one call' solution for donor organ recovery, combining air and ground transportation with surgical procurement and advanced organ preservation. Its core value proposition centers on increasing the success rate of transplants through a nationwide network and proprietary technology that streamlines complex medical coordination.

Competitive position

Strata is one of the nation's largest air transport and surgical services networks for the transplant industry, distinguishing itself through an integrated 'one call' service model.

GeographiesUnited States

Customer segmentsTransplant Hospitals, Organ Procurement Organizations, Cardiac Surgery Centers

Business modelAsset-light logistics, Service-based staffing, Equipment leasing, Contractual retainer and fee-for-service

SuppliersThird-party Part 135 aircraft operators, Aircraft maintenance providers, Medical equipment manufacturers, Specialized clinical practitioners (surgeons and perfusionists)

CustomersTransplant centers, Organ procurement organizations, Hospitals, Cardiovascular surgery centers

CountryUnited States of America

Listed2021

CEOMelissa Tomkiel

SectorIndustrials

IndustryAirlines, Airports & Air Services

Websitestratacritical.com

FilingsSEC EDGAR

Ask your AI about Strata Critical Medical, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Strata Critical Medical, Inc.'s market cap?: Strata Critical Medical, Inc. (SRTA) has a market capitalization of $444.7M and trades on NASDAQ.
What is Strata Critical Medical, Inc.'s revenue and profitability?: Strata Critical Medical, Inc. generated $254.3M in trailing twelve-month revenue with net income of $52.3M, representing a net margin of 21.0%. Gross margin stands at 21.7%, with free cash flow of -$56.9M. These figures are based on the Q1 2026 filing.
Who are Strata Critical Medical, Inc.'s competitors?: Strata Critical Medical, Inc.'s key competitors include TransMedics Group, Inc. Common Stock, Universal Logistics Holdings, Inc. Common Stock, Landstar System Inc, and others. These companies compete in similar markets and product categories.
What subsidiaries does Strata Critical Medical, Inc. have?: Strata Critical Medical, Inc.'s subsidiaries include Trinity Medical Solutions, Keystone Perfusion Services LLC.
Where is Strata Critical Medical, Inc. headquartered?: Strata Critical Medical, Inc. is headquartered in United States of America. It has been publicly traded since 2021.